--- title: Buy Gleevec (Imatinib) 100mg, 400mg Pills Online description: Gleevec (Imatinib) 100mg/400mg is a trusted treatment for certain leukemias and cancers. Order from our secure pharmacy for verified quality delivery. type: product language: en url: https://medsforsale.net/buy-gleevec-online-en availability: in_stock price_min: 72.99 price_max: 839.99 currency: USD offers: - name: 100mg x 10 pills price: 72.99 - name: 100mg x 20 pills price: 127.99 - name: 100mg x 30 pills price: 164.99 - name: 100mg x 60 pills price: 274.99 - name: 400mg x 10 pills price: 182.99 - name: 400mg x 20 pills price: 311.99 - name: 400mg x 30 pills price: 439.99 - name: 400mg x 60 pills price: 839.99 --- # Buy Gleevec (Imatinib) 100mg, 400mg Pills Online Gleevec, featuring the active ingredient Imatinib, is a revolutionary tyrosine kinase inhibitor originally developed by Novartis. It is utilized to treat various types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors. It is intended for patients requiring targeted therapy to block the growth of cancer cells. You can access Gleevec through our secure online pharmacy in both 100mg and 400mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **100mg** | 10 pills | **$72.99** | $7.30 | In Stock | | **100mg** | 20 pills | **$127.99** | $6.40 | In Stock | | **100mg** | 30 pills | **$164.99** | $5.50 | In Stock | | **100mg** | 60 pills | **$274.99** | $4.58 | In Stock | | **400mg** | 10 pills | **$182.99** | $18.30 | In Stock | | **400mg** | 20 pills | **$311.99** | $15.60 | In Stock | | **400mg** | 30 pills | **$439.99** | $14.67 | In Stock | | **400mg** | 60 pills | **$839.99** | $14.00 | In Stock | [Buy Now](https://medsforsale.net/buy-gleevec-online-en) ## Introduction Imatinib, sold under the generic name **Gleevec**, is a targeted oral anticancer agent indicated for several approved hematologic and solid-tumor malignancies. The medication is supplied as film-coated tablets in strengths of 100 mg and 400 mg. It belongs to the class of tyrosine-kinase inhibitors (TKIs) and works by blocking specific cellular signaling pathways that drive uncontrolled cell growth. In addition to its primary indications, imatinib has been investigated for a number of off-label applications, although such uses remain outside formal regulatory approval. --- ## What is Gleevec? Gleevec is the generic version of well-known medications, containing the active compound **Imatinib**. [our online pharmacy](https://medsforsale.net/buy-gleevec-online-en) provides this generic alternative as a cost-effective treatment option. Imatinib is a small-molecule inhibitor originally developed by Novartis and first approved by the U.S. Food and Drug Administration (FDA) in 2001. It is classified as a selective BCR-ABL, c-KIT, and PDGFR tyrosine-kinase inhibitor. Commercially, the same molecule is marketed under brand names such as **Gleevec** and **Glivec** in various regions. The drug is supplied as oral tablets, each containing either 100 mg or 400 mg of imatinib mesylate. --- ## How Gleevec Works Imatinib binds competitively to the ATP-binding pocket of the BCR-ABL fusion protein, the abnormal tyrosine kinase produced by the Philadelphia chromosome translocation (t(9;22)). By occupying this pocket, the drug blocks phosphorylation of downstream substrates, halting the proliferative signal that drives chronic myeloid leukemia (CML) cells. The same mechanism applies to other kinases-c-KIT and platelet-derived growth factor receptors (PDGFR-α/β)-which explains its activity in gastrointestinal stromal tumors (GIST) and certain systemic mastocytosis forms. The inhibition is rapid, with measurable suppression of kinase activity within hours after oral intake. Imatinib’s half-life is approximately 18 hours, allowing once-daily dosing for most indications. Metabolism occurs primarily via CYP3A4, and the drug is excreted mainly in feces. --- ## Conditions Treated with Gleevec - **Chronic Myeloid Leukemia (CML), chronic phase** - Imatinib is first-line therapy because it directly targets the BCR-ABL oncoprotein, leading to durable hematologic and cytogenetic remissions. - **Accelerated or blast phase CML (in combination with other agents)** - The drug reduces leukemic burden, though additional chemotherapy is usually required. - **Philadelphia-chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)** - Imatinib, combined with standard ALL regimens, improves remission rates by suppressing BCR-ABL activity. - **Gastrointestinal stromal tumor (GIST) with KIT or PDGFRA mutations** - By inhibiting mutated KIT/PDGFRA receptors, imatinib controls tumor growth and reduces recurrence after surgical resection. - **Aggressive systemic mastocytosis** - In patients harboring KIT D816V mutations, imatinib attenuates mast cell proliferation and mediator release. For each of these approved uses, the drug’s ability to block the specific driver kinase is the scientific rationale for its efficacy. --- ## Off-Label and Investigational Uses of Gleevec - **Dermatofibrosarcoma protuberans (DFSP)** - Small case series have reported tumor regression when imatinib targets the COL1A1-PDGFB fusion gene. - **Hypereosinophilic syndrome (HES) with PDGFRA rearrangements** - Clinical studies show rapid hematologic normalization when the abnormal PDGFRA kinase is inhibited. - **Alveolar soft part sarcoma** - Limited phase-II data suggest disease stabilization in a minority of patients with TFE3-related translocations. - **Myelodysplastic syndromes (MDS) with specific cytogenetic abnormalities** - Early trials indicate possible hematologic improvement, though results are not conclusive. These applications are not approved by the FDA, EMA, or other major regulators. Use should occur only under the direct supervision of a qualified healthcare professional, with careful monitoring for efficacy and toxicity. --- ## Is Gleevec the Right Medication for You? Imatinib is most appropriate for adult patients with documented BCR-ABL-positive leukemias, KIT- or PDGFRA-mutated GIST, or systemic mastocytosis meeting specific molecular criteria. It is preferred when the disease driver is a known target of the drug, as this predicts higher response rates. Patients with severe hepatic impairment (Child-Pugh C) or known hypersensitivity to imatinib or any tablet excipient should avoid the medication. Caution is advised in individuals with congestive heart failure, uncontrolled arrhythmias, or a history of severe cytopenias, because the drug can exacerbate these conditions. --- ## Risks, Side Effects, and Interactions ### Common - Nausea, vomiting, or abdominal discomfort - Periorbital edema and peripheral edema - Muscle cramps or myalgia - Diarrhea or constipation - Skin rash, pruritus, or erythema ### Rare - Elevated pancreatic enzymes (amylase, lipase) - Hypophosphatemia or other electrolyte disturbances - Mild hepatic transaminase elevation ### Serious - Severe neutropenia or thrombocytopenia leading to infection or bleeding - Hepatotoxicity (grade 3-4 ALT/AST elevation) - Congestive heart failure exacerbation - Pulmonary arterial hypertension (PAH) - rare but potentially fatal; monitor for dyspnea, fatigue, or syncope ### Drug-Drug and Drug-Food Interactions - **CYP3A4 inhibitors** (e.g., ketoconazole, clarithromycin) increase imatinib plasma levels → may require dose reduction. - **CYP3A4 inducers** (e.g., rifampin, carbamazepine, St. John’s wort) lower exposure → may reduce efficacy. - Antacids containing magnesium or aluminum do **not** affect absorption, but concomitant use of proton-pump inhibitors may modestly decrease bioavailability. - Concomitant anticoagulants (warfarin, direct oral anticoagulants) can have increased bleeding risk when thrombocytopenia occurs. - Live vaccines are contraindicated while on imatinib due to immunosuppression. Patients should disclose all current medications, supplements, and over-the-counter products to their prescriber. --- ## Use: Dosing, Missed Dose, Overdose Standard dosing varies by indication: - **CML (chronic phase)** - 400 mg once daily, usually as a single 400 mg tablet. - **GIST (adjuvant or unresectable)** - 400 mg daily, divided as 400 mg once or 200 mg twice if gastrointestinal tolerance is an issue. - **Systemic mastocytosis** - 100 mg daily, titrated upward based on response and tolerability, not exceeding 400 mg. **Missed dose:** Take the missed tablet as soon as it is remembered, unless the next scheduled dose is within six hours. In that case, skip the missed dose and resume the regular dosing schedule. Do not double-dose. **Overdose:** Symptoms may include severe nausea, vomiting, dizziness, or cardiac arrhythmia. Seek immediate medical attention; supportive care is the mainstay of treatment. **Practical precautions:** Imatinib may be taken with or without food; a light meal can lessen gastrointestinal upset. Alcohol does not directly interact, but excessive intake can worsen liver toxicity. Patients should avoid operating heavy machinery until they know how the drug affects them, especially during the first weeks of therapy. --- ## FAQ - **What should I do with Gleevec tablets if I travel internationally?**   Store the medication in its original container at room temperature, protected from moisture and direct sunlight. Carry it in hand luggage to avoid temperature extremes in cargo holds, and keep a copy of the prescription or a physician’s letter for customs inspection if required. - **Can I split a 400 mg Gleevec tablet for dose adjustment?**   The 400 mg tablet is scored and can be divided accurately to achieve lower doses. Splitting should be done with a clean tablet-splitting device, and the halves must be taken together to maintain consistent exposure. - **Are there any excipients in Gleevec that could trigger an allergy?**   Inactive ingredients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with known lactose intolerance or hypersensitivity to these compounds should discuss alternatives with their clinician. - **How long does a typical Gleevec shipment take to the United States?**   Standard airmail from our partnered overseas pharmacies usually arrives within 10-21 days, while express services can deliver in 5-7 days, subject to local customs processing. - **Is Gleevec considered a performance-enhancing drug in sports testing?**   Imatinib is not listed on the World Anti-Doping Agency (WADA) prohibited substance list. However, athletes should disclose any medication use to their governing body, as proprietary testing panels may detect it. - **Does Gleevec interact with hormonal contraceptives?**   No clinically relevant pharmacokinetic interaction has been documented between imatinib and combined oral contraceptives. Nevertheless, consistent use of contraception is advised because disease-related factors can affect fertility. - **Can Gleevec be taken during pregnancy or breastfeeding?**   Animal studies show embryotoxic effects, and human data are limited. The medication is generally contraindicated in pregnancy unless the therapeutic benefit outweighs the potential fetal risk. It is excreted in breast milk; breastfeeding is usually discouraged. - **Why does my hair turn gray or thin while on Gleevec?**   Tyrosine-kinase inhibition can affect melanocyte function and hair follicle cycling, leading to depigmentation or thinning in some patients. The change is reversible after discontinuation, but permanent loss has been reported rarely. - **What laboratory monitoring is required while on Gleevec?**   Baseline and periodic complete blood counts, liver function tests, and renal panels are recommended. Additional monitoring for cardiac function (e.g., echocardiogram) is advised for patients with prior heart disease or signs of fluid overload. - **Is there a difference between Gleevec and Glivec formulations?**   Both names refer to the same imatinib mesylate molecule; the variation is purely branding for different geographic markets. The dosage strengths, tablet composition, and clinical efficacy are equivalent. --- ## Glossary **Tyrosine-kinase inhibitor (TKI)** : A class of drugs that block enzymes (tyrosine kinases) responsible for signaling pathways that control cell growth and division. **BCR-ABL fusion protein** : An abnormal enzyme produced by the Philadelphia chromosome translocation; it drives uncontrolled proliferation in chronic myeloid leukemia. **Pharmacokinetics** : The study of how a drug is absorbed, distributed, metabolized, and excreted by the body. **Hepatotoxicity** : Liver injury caused by a medication, which may be detected by elevated liver enzymes or clinical signs of liver dysfunction. --- ## Buying Gleevec from [our online pharmacy](https://medsforsale.net/buy-gleevec-online-en) Patients seeking a reliable source of imatinib can obtain the generic medication from **[our online pharmacy](https://medsforsale.net/buy-gleevec-online-en)**. By partnering with licensed overseas suppliers, we are able to offer a price that approaches the manufacturer’s cost while preserving strict quality standards. Every batch is verified for authenticity and potency before shipment, ensuring that you receive a product that meets regulatory specifications. Our fulfillment system provides discreet packaging and reliable delivery timelines-express shipping typically arrives within a week, and standard airmail within two to three weeks. Because the service operates as a pharmacy broker, we can source imatinib for individuals who encounter limited access through conventional channels or whose insurance plans do not cover the medication. Privacy is a core commitment; orders are processed anonymously, and all personal information is protected by secure encryption. Choosing **[our online pharmacy](https://medsforsale.net/buy-gleevec-online-en)** means gaining a cost-effective, trustworthy, and confidential avenue to obtain Gleevec when you need it. --- ## Disclaimer The material presented about **Gleevec** serves solely as general informational content and does not substitute professional medical advice. Treatment choices, including any off-label applications, must be made under the direct supervision of a qualified health-care provider. Readers are presumed to be competent adults capable of evaluating health-related information responsibly. [our online pharmacy](https://medsforsale.net/buy-gleevec-online-en) supplies **Gleevec** to individuals who might encounter difficulty obtaining the drug through conventional pharmacy networks, insurance formularies, or who are pursuing more affordable generic alternatives. Always discuss any medication changes, initiation, or discontinuation with your clinician before proceeding.